AN2 Therapeutics, Inc.
USD5.02
-0.01 (-0.20%)
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.01
Prev. Close
$5.03
Day Low
$4.92
Day High
$5.10
52W Low
$1.00
52W High
$6.91
Market Cap
$0.14B
Volume
0.02M
| 25 Feb 2025 | Citizens Capital Markets | Market Outperform | Market Outperform | maintain |
| 3 Feb 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 19 Nov 2024 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 18 Nov 2024 | TD Cowen | Buy | Hold | downgrade |
| 9 Aug 2024 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 3 Jul 2024 | Leerink Partners | Market Perform | Outperform | upgrade |
| 16 May 2024 | Evercore ISI Group | In Line | In Line | maintain |